Related Experiment Videos

Clinical outcomes for low-income adults with hypertension and diabetes

Linda Ciofu Baumann1, Mei-Wei Chang, Roberta Hoebeke

  • 1Academic Nursing Practice, University of Wisconsin-Madison School of Nursing, 53792-2455, USA. ljbauman@facstaff.wisc.edu

Nursing Research
|June 14, 2002
PubMed

Insights

Health disparities persist in hypertension and diabetes management among minority populations. Interventions promoting healthy lifestyles are crucial for reducing these gaps in low-income communities.

Area of Science:

  • Public Health
  • Health Disparities Research
  • Chronic Disease Management

Background:

  • Hypertension and diabetes disproportionately affect minority and socioeconomically disadvantaged populations.
  • Community health centers face challenges in managing these chronic conditions.
  • Existing healthcare models may not adequately address the needs of these vulnerable groups.

Purpose of the Study:

  • To examine health outcomes for individuals with hypertension and diabetes.
  • To compare health outcomes across racial/ethnic groups (Black, Hispanic, White) to identify disparities.

Main Methods:

  • Retrospective review of medical records (N=280) from an urban community health center serving uninsured adults.
  • Analysis of clinical outcomes including hypertension and diabetes control, lifestyle behaviors, and preventive care.
  • Statistical analysis using chi-square tests, t tests, and analysis of covariance to compare racial/ethnic group differences.

Main Results:

  • Significant differences observed in smoking status, influenza immunization rates, and blood pressure control.
  • Racial/ethnic disparities in outcomes were minimal compared to the high prevalence of risk factors like smoking and obesity.
  • Access to regular primary care did not correlate with improved clinical outcomes.

Conclusions:

  • Findings underscore the need for targeted interventions to promote healthy lifestyles.
  • Effective strategies are essential to reduce health disparities in low-income populations with chronic conditions.
  • Further research into culturally sensitive and effective interventions is warranted.
Abstract

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...